Kaleido Biosciences Inc KLDO

NAS: KLDO | ISIN: US4833471000 17:44

0,000 USD (0,00%)

(0,00%) 17:44

Grafiek Kaleido Biosciences Inc

Grafiek Kaleido Biosciences Inc

1 dag1d 0,00%
1 week1w 0,00%
1 maand1m 0,00%
3 maanden3m 0,00%
6 maanden6m 0,00%
1 jaar1j -50,00%
5 jaar5j -100,00%

Kaleido Biosciences Inc in het nieuws

Toon enkel gratis nieuws

28 februari 2022 · Alltrna Appoints Rare Disease Clinical Research Expert, Dr. Anne Pariser, as Vice President, Medical and Regulatory Affairs · Persbericht

15 februari 2022 · Invaio Sciences Strengthens Its Board Of Directors With The Appointment Of Hugh Grant · Persbericht

13 oktober 2021 · Invaio Sciences Secures $50 Million Debt Financing to Develop and Commercialize Agricultural Solutions to Address Climate Change · Persbericht

25 mei 2021 · Invaio Sciences Raises $88.9 Million to Accelerate the Transition to Biological Agriculture · Persbericht

19 mei 2021 · Invaio Sciences Announces Key Agreement with Fundecitrus in Brazil to Combat Against Citrus Greening · Persbericht

30 maart 2021 · Invaio Sciences Strengthens Leadership Team with Appointment of Peleg Chevion as President and Chief Commercial Officer · Persbericht

3 maart 2021 · Kaleido Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results · Persbericht

1 maart 2021 · Kaleido Biosciences to Present at Chardan’s 3rd Annual Microbiome Medicines Summit · Persbericht

25 februari 2021 · Cellarity Raises $123 Million in Series B Funding to Pioneer a New Approach to Drug Discovery, Treating Disease at the Level of the Cell as Opposed to a Single Molecular Target · Persbericht

11 februari 2021 · Kaleido Biosciences Announces the Exercise of the Underwriters’ Option to Purchase Additional Shares of Common Stock · Persbericht

Profiel Kaleido Biosciences Inc

Gezondheidstechnologie

Medicinale en botanische productie

Werknemers: 82

Aandelen Kaleido Biosciences Inc

Effecten: 42,62 miljoen

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe